Does oxidative stress play a critical role in cardiovascular complications of kawasaki disease?

Antioxidants and Redox Signaling

Volumn 17, Issue 10, 2012, Pages 1441-1446

  Straface, Elisabetta ^a   Marchesi, Alessandra ^b   Gambardella, Lucrezia ^a   Metere, Alessio ^a   De Jacobis, Isabella Tarissi ^b   Viora, Marina ^a   Giordani, Luciana ^a   Villani, Alberto ^b   Del Principe, Domenico ^a   Malorni, Walter ^a,c   Pietraforte, Donatella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c San Raffaele Institute Sulmona   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CD47 ANTIGEN; GLYCOPHORIN A; MYELOPEROXIDASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHATIDYLSERINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; THIOL;

BIOSYNTHESIS; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME BLOOD LEVEL; ERYTHROCYTE; HOMEOSTASIS; HUMAN; HUMAN CELL; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; NITRATIVE STRESS; OXIDATIVE STRESS; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TYROSINE;

EID: 84866294575     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4660     Document Type: Review

References (9)

1. Baker AL and Newburger JW. Kawasaki disease. Circulation 118: 110-112, 2008.
2. Baldus S, Eiserich JP, Brennan M-L, Jackson RM, Alexander CB, and Freeman BA. Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radic Biol Med 33: 1010-1019, 2002. (Pubitemid 35284038)
3. Cheung Y, O. K, Woo CH, Armstrong S, Siow YL, Chow PC, and Cheung EWY. Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness. BMC Pediatr 8: 8-20, 2008.
4. Kaneko K, Takahashi M, Yoshimura K, Kitao T, Yamanouchi S, Kimata T, and Tsuji S. Intravenous immunoglobulin counteracts oxidative stress in Kawasaki disease. Pediatr Cardiol 2012 [Epub ahead of print]; DOI: 10.1007/s00246-012- 0229-4.
5. Kuo HC, Yang KD, Chang WC, Ger LP, and Hsieh KS. Kawasaki disease: an update on diagnosis and treatment. Pediatr Neonatol 53: 4-11, 2012.
6. Kuo HC, Yang YL, Chuang JH, Tiao MM, Yu HR, Huang LT, Yang KD, Chang WC, Lee CP, and Huang YH. Inflammationinduced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease. J Clin Immunol 2012 [Epub ahead of print]; DOI: 10.1007/s10875-012-9668-1.
7. Lang F, Lang KS, Lang PA, Huber SM, and Wieder T. Mechanisms and significance of eryptosis. Antioxid Redox Signal 8: 1183-1192, 2006. (Pubitemid 44182417)
8. Lucantoni G, Pietraforte D, Matarrese P, Gambardella L, Metere A, Paone G, Li Bianchi E, and Straface E. The red blood cell as a biosensor for monitoring oxidative imbalance in chronic obstructive pulmonary disease: an ex vivo and in vitro study. Antioxid Redox Signal 8: 1171-1182, 2006. (Pubitemid 44182416)
9. Straface E, Gambardella L, Metere A, Marchesi A, Palumbo G, Cortis E, Villani A, Pietraforte D, Viora M, Malorni W, and Principe DD. Oxidative stress and defective platelet apoptosis in na?̈ve patients with Kawasaki disease. Biochem Biophys Res Commun 392: 426-430, 2010.